Published online before print November 22, 2006, doi: 10.1161/01.RES.0000253533.65446.33
© 2006 American Heart Association, Inc.
Molecular Medicine |
Regulation of Smooth Muscle Cell Proliferation by ß-Catenin/T-Cell Factor Signaling Involves Modulation of Cyclin D1 and p21 Expression
From the Bristol Heart Institute (H.Q., S.C.S., C.A.B., G.B.S.-N., S.J.G.), Level 7, Bristol Royal Infirmary, Upper Maudlin St, BRISTOL, BS2 8HW, UK, Cardiovascular Branch (M.B.), National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Correspondence to Dr Sarah Jane George, Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Upper Maudlin St BRISTOL, BS2 8HW. E-mail s.j.george{at}bris.ac.uk
We previously observed that stimulation of vascular smooth muscle cell (VSMC) proliferation with growth factors is associated with dismantling of cadherin junctions and nuclear translocation of ß-catenin. In this study we demonstrate directly that growth factors stimulate ß-catenin/T-cell factor (TCF) signaling in primary VSMCs. To determine whether ß-catenin/TCF signaling regulates VSMC proliferation via modulation of the ß-catenin/TCF responsive cell cycle genes, cyclin D1 and p21, we inhibited ß-catenin/TCF signaling by adenoviral-mediated over-expression of N-Cadherin, ICAT (an endogenous inhibitor of ß-catenin/TCF signaling), or a dominant negative (dn) mutant of TCF-4. N-cadherin, ICAT or dnTCF-4 over-expression significantly reduced proliferation of isolated human VSMCs by approximately 55%, 80%, and 45% respectively. Similar effects were observed in human saphenous vein medial segments where proliferation was reduced by approximately 55%. Transfection of dnTCF-4 in the ISS10 human VSMC line significantly lowered TCF and cyclin D1 reporter activity but significantly elevated p21 reporter activity, indicating regulation of these genes by ß-catenin/TCF signaling. In support of this, over-expression of N-cadherin, ICAT or dnTCF-4 in isolated human VSMCs significantly lowered levels of cyclin D1 mRNA and protein levels. In contrast, over-expression of N-Cadherin, ICAT or dnTCF4 significantly elevated p21 mRNA and protein levels. In summary, we have demonstrated that increasing N-cadherin and inhibiting ß-catenin/TCF signaling reduces VSMC proliferation, decreases the expression of cyclin D1 and increases levels of the cell cycle inhibitor, p21. We therefore suggest that the N-cadherin and ß-catenin/TCF signaling pathway is a key modulator of VSMC proliferation via regulation of these 2 ß-catenin/TCF responsive genes.
Key Words: smooth muscle • proliferation • cell cycle
Related Article:
Circ. Res. 2006 99: 1287-1289.
This article has been cited by other articles:
 |
|
 |
|
  C. A. Lyon, J. L. Johnson, H. Williams, G. B. Sala-Newby, and S. J. George Soluble N-Cadherin Overexpression Reduces Features of Atherosclerotic Plaque Instability Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 195 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dwivedi, S. C. Slater, and S. J. George MMP-9 and -12 cause N-cadherin shedding and thereby {beta}-catenin signalling and vascular smooth muscle cell proliferation Cardiovasc Res, January 1, 2009; 81(1): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liebner, M. Corada, T. Bangsow, J. Babbage, A. Taddei, C. J. Czupalla, M. Reis, A. Felici, H. Wolburg, M. Fruttiger, et al. Wnt/{beta}-catenin signaling controls development of the blood-brain barrier J. Cell Biol., November 3, 2008; 183(3): 409 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bedel, A. Negre-Salvayre, S. Heeneman, M.-H. Grazide, J.-C. Thiers, R. Salvayre, and F. Maupas-Schwalm E-Cadherin/{beta}-Catenin/T-Cell Factor Pathway Is Involved in Smooth Muscle Cell Proliferation Elicited by Oxidized Low-Density Lipoprotein Circ. Res., September 26, 2008; 103(7): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Giordano, S. Romano, M. Mallardo, A. D'Angelillo, G. Cali, N. Corcione, P. Ferraro, and M. F. Romano FK506 can activate transforming growth factor-{beta} signalling in vascular smooth muscle cells and promote proliferation Cardiovasc Res, August 1, 2008; 79(3): 519 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hou, K. Okada, C. Okamoto, S. Ueshima, and O. Matsuo Alpha2-Antiplasmin Is a Critical Regulator of Angiotensin II-Mediated Vascular Remodeling Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1257 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Nunes, M. Schmidt, G. Dueck, H. Baarsma, A. J. Halayko, H. A. M. Kerstjens, H. Meurs, and R. Gosens GSK-3/{beta}-catenin signaling axis in airway smooth muscle: role in mitogenic signaling Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1110 - L1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taurin, N. Sandbo, D. M. Yau, N. Sethakorn, and N. O. Dulin Phosphorylation of {beta}-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1169 - C1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. George Wnt Pathway: A New Role in Regulation of Inflammation Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 400 - 402. [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Cohen, Y. Tian, and E. E. Morrisey Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal Development, March 1, 2008; 135(5): 789 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Kirton, N. J. Crofts, S. J. George, K. Brennan, and A. E. Canfield Wnt/{beta}-Catenin Signaling Stimulates Chondrogenic and Inhibits Adipogenic Differentiation of Pericytes: Potential Relevance to Vascular Disease? Circ. Res., September 14, 2007; 101(6): 581 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Couffinhal, P. Dufourcq, and C. Duplaa {beta}-Catenin Nuclear Activation: Common Pathway Between Wnt and Growth Factor Signaling in Vascular Smooth Muscle Cell Proliferation? Circ. Res., December 8, 2006; 99(12): 1287 - 1289. [Full Text] [PDF]
|
|